title: Risk of relapse in primary acute anterior uveitis.
abstract: OBJECTIVE
  To evaluate the risk of and risk factors for a second episode (relapse) among patients with remitted primary anterior uveitis.
  
  
  METHODS
  Retrospective cohort study.
  
  
  METHODS
  Patients with primary anterior uveitis presenting to 1 of 4 academic ocular inflammation subspecialty practices achieving remission of the primary episode within 90 days of initial uveitis diagnosis.
  
  
  METHODS
  Data were obtained by standardized chart review.
  
  
  METHODS
  Time to relapse of anterior uveitis and risk factors for relapse.
  
  
  RESULTS
  We included 102 patients with a first episode of anterior uveitis who were seen within 90 days of first-ever uveitis onset and followed for 165 person-years after achieving remission of the initial episode. Most patients were female (60%) and white (78%). Forty patients had a recurrence of anterior uveitis. The incidence of relapse was 24% per person-year (95% confidence interval [CI], 17%-33%). At 1.5 years after remission, 61% (95% CI, 48%-71%) were still in remission. Younger adults had significantly higher relapse risk than middle-aged adults (hazard ratio [18- to 35-year-old persons vs. 35- to 55-year-old persons], 2.7; 95% CI, 1.3-6.0).
  
  
  CONCLUSIONS
  Our results suggest that many patients with remitted primary anterior uveitis presenting for tertiary uveitis care will relapse. Age in the young adult range was associated with higher risk of relapse. Given the high relapse risk, management of patients with primary anterior uveitis should include an explicit plan for detecting and managing relapses.
  
  
  BACKGROUND
  Proprietary or commercial disclosure may be found after the references.
authors.affiliation: Department of Ophthalmology, The University of Pennsylvania, Philadelphia, PA 19104, USA.
authors.forename: Lili
authors.initials: L
authors.lastname: Grunwald
authors.forename: Craig W
authors.initials: CW
authors.lastname: Newcomb
authors.forename: Ebenezer
authors.initials: E
authors.lastname: Daniel
authors.forename: R Oktay
authors.initials: RO
authors.lastname: Kaçmaz
authors.forename: Douglas A
authors.initials: DA
authors.lastname: Jabs
authors.forename: Grace A
authors.initials: GA
authors.lastname: Levy-Clarke
authors.forename: Robert B
authors.initials: RB
authors.lastname: Nussenblatt
authors.forename: James T
authors.initials: JT
authors.lastname: Rosenbaum
authors.forename: Eric B
authors.initials: EB
authors.lastname: Suhler
authors.forename: Jennifer E
authors.initials: JE
authors.lastname: Thorne
authors.forename: C Stephen
authors.initials: CS
authors.lastname: Foster
authors.forename: John H
authors.initials: JH
authors.lastname: Kempen
mesh_terms: D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D018570:Risk Assessment; D012307:Risk Factors; D013997:Time Factors; D014606:Uveitis, Anterior / Q000175:diagnosis* / Q000453:epidemiology; D055815:Young Adult